Sep 17 |
OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc
|
Sep 16 |
With 55% ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) boasts of strong institutional backing
|
Sep 15 |
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
|
Sep 15 |
Should You Invest in This Under-the-Radar Weight Loss Stock?
|
Sep 14 |
1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More
|
Sep 12 |
Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
Sep 12 |
Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More
|
Sep 11 |
Terns Pharmaceuticals prices $150M stock offering
|
Sep 11 |
Terns Announces Pricing of Upsized $150.15 Million Public Offering
|
Sep 10 |
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
|